Vanguard Capital Management
NVAX icon

Vanguard Capital Management’s Novavax NVAX Stock Holding History

Vanguard Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$68.4M Buy
7,257,449
+127,302
+2% +$1.14M ﹤0.01% 1766
2026
Q1 		$58M Buy
+7,130,147
New +$64.6M ﹤0.01% 1787

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management's NVAX Position: Q2 2026 in Review

Vanguard Capital Management increased its Novavax (NVAX) stake by 1.8% in Q2 2026, buying an estimated $1.14M and bringing the position to 7,257,449 shares worth $68.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1766.

Vanguard Capital Management first reported a position in NVAX in Q1 2026 and has held it in 2 quarters since. 264 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Vanguard Capital Management held 7,257,449 shares of Novavax worth $68.4M as of Q2 2026.
  • Vanguard Capital Management bought 127,302 Novavax shares in Q2 2026, an estimated $1.14M.
  • Novavax made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #1766 holding.
  • Vanguard Capital Management first reported a position in Novavax in Q1 2026 and has held it in 2 quarters since.
  • 264 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.